Cargando…

Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with malignant hematologic diseases. Killer immunoglobin-like receptor (KIR) expressed by NK cells is closely associated with the transplant outcomes, and it has been widely explored and debated for a few decades. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yanmin, Gao, Fei, Wu, Yibo, Shi, Jimin, Luo, Yi, Tan, Yamin, Yu, Jian, Lai, Xiaoyu, Zhang, Mingming, Zhang, Wei, Huang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901980/ https://www.ncbi.nlm.nih.gov/pubmed/33633734 http://dx.doi.org/10.3389/fimmu.2020.614488

Ejemplares similares

Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
por: Zhang, Yu, et al.
Publicado: (2023)

Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin–Based T-Cell–Replete Haploidentical Hematopoietic Stem Cell Transplant
por: Wu, Hengwei, et al.
Publicado: (2022)

Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation
por: Liu, Jiangying, et al.
Publicado: (2015)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)

Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation
por: Yuan, Jiaojiao, et al.
Publicado: (2017)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017)

PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION
por: chen, X., et al.
Publicado: (2022)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Rabbit Antithymocyte Globulin Causes Blastomyces and Histoplasma Antigenemia
por: Kaur, Amrit, et al.
Publicado: (2019)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
por: Lin, Ren, et al.
Publicado: (2019)

Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2020)

Successful desensitization of a patient with aplastic anemia to antithymocyte globulin
por: Wolanin, Stephanie A., et al.
Publicado: (2015)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
por: Rafat, Shamim, et al.
Publicado: (2017)

Severe Acute Interstitial Nephritis: Response to Therapy With Antithymocyte Globulin
por: Shao, Tiffany, et al.
Publicado: (2016)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

Antithymocyte-globulin/mycophenolate-mophetil: Lymphopenia: 3 case reports
Publicado: (2021)

Antithymocyte globulin/methylprednisolone: COVID-19 infection: case report
Publicado: (2021)

Antithymocyte-globulin/ciclosporin/eltrombopag: Lack of efficacy: case report
Publicado: (2022)

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants
por: Wang, Hong, et al.
Publicado: (2017)

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
por: Vieri, Margherita, et al.
Publicado: (2023)

P1394: DIFFERENT DOSES OF ANTITHYMOCYTE GLOBULIN (ATG) AS PART OF THE PREPARATIVE REGIMEN IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
por: Zhou, S., et al.
Publicado: (2022)

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
por: Roider, Tobias, et al.
Publicado: (2016)

Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
por: Zimmermann, SY, et al.
Publicado: (2002)

Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients
por: Lee, Grace Pui-Yun, et al.
Publicado: (2022)

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
por: Zhao, X-Y, et al.
Publicado: (2014)

Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia
por: Andreani, Marco, et al.
Publicado: (2017)

NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs
por: Ichise, Hiroshi, et al.
Publicado: (2017)

A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
por: Lee, Myung-Won, et al.
Publicado: (2020)

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia
por: Kekre, Natasha, et al.
Publicado: (2017)

Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
por: Saidi, R. F., et al.
Publicado: (2011)

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018)

Antithymocyte-globulin: Worsening of SARS-CoV-2 infection: case report
Publicado: (2020)

Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
por: Kitto, Brent, et al.
Publicado: (2021)

The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation
por: Linhares, Kamilla, et al.
Publicado: (2021)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
por: Pourmand, G. R., et al.
Publicado: (2012)

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study
por: Harrison, Jennifer J, et al.
Publicado: (2014)

Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin
por: Liu, Wenbin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i07901nfe5dsegj7ba4k0u4pqi